Crossmark

Authors’ Reply to Khan et al. “Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials”

Crossref DOI link: https://doi.org/10.1007/s40256-025-00779-0

Published Online: 2026-01-04

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rangwala, Hussain Sohail https://orcid.org/0009-0007-2167-3481
Fatima, Hareer

Ali, Mirha

Shafique, Muhammad Ashir

Rangwala, Burhanuddin Sohail

Virwani, Vikash

Kumar, Aashish

Arsal, Syed Ali

Raja, Adarsh

Raja, Sandesh

Mustafa, Muhammad Saqlain
License Information

Text and Data Mining valid from 2026-01-04

Version of Record valid from 2026-01-04
More Information

Article History

Received: 26 November 2025

Accepted: 27 November 2025

First Online: 4 January 2026

Declarations

:

: Hussain Sohail Rangwala, Hareer Fatima, Mirha Ali, Muhammad Ashir Shafique, Burhanuddin Sohail Rangwala, Vikash Virwani, Aashish Kumar, Syed Ali Arsal, Adarsh Raja, Sandesh Raja, and Muhammad Saqlain Mustafa declare that they have no potential conflicts of interest that might be relevant to the contents of this letter.

: All authors have read and agreed to the final version of this letter.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below